Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome.

[1]  Y. Shoenfeld,et al.  HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. , 2011, Seminars in arthritis and rheumatism.

[2]  Z. Blumenfeld,et al.  Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases. , 2011, Seminars in arthritis and rheumatism.

[3]  Mimi Y. Kim,et al.  Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus , 2011, Circulation.

[4]  A. Walfisch,et al.  The transfer of 6-mercaptopurine in the dually perfused human placenta. , 2011, Reproductive toxicology.

[5]  A. Bérard,et al.  Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion , 2011, Canadian Medical Association Journal.

[6]  P. Meroni,et al.  In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions. , 2011, Blood.

[7]  F. Gadler,et al.  Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern , 2011, Annals of the rheumatic diseases.

[8]  A. Tincani,et al.  Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. , 2011, Rheumatology.

[9]  Y. Sai,et al.  6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs. , 2011, Journal of pharmaceutical sciences.

[10]  M. Micu,et al.  Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies , 2011, Arthritis care & research.

[11]  S. Bewley,et al.  Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis , 2011, The Journal of Rheumatology.

[12]  D. Friedman,et al.  Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. , 2011, Arthritis and rheumatism.

[13]  C. Gordon,et al.  Causes and management of infertility in systemic lupus erythematosus. , 2011, Rheumatology.

[14]  I. Bruce,et al.  Decreased live births in women with systemic lupus erythematosus , 2011, Arthritis care & research.

[15]  M. Khamashta,et al.  Lupus and pregnancy: integrating clues from the bench and bedside , 2011, European journal of clinical investigation.

[16]  P. Meroni,et al.  Pathogenesis of antiphospholipid syndrome: understanding the antibodies , 2011, Nature Reviews Rheumatology.

[17]  L. Magder,et al.  The Clinical Utility of Measuring Complement and Anti-dsDNA Antibodies During Pregnancy in Patients with Systemic Lupus Erythematosus , 2011, The Journal of Rheumatology.

[18]  Caroline Gordon,et al.  Pregnancy and reproduction in autoimmune rheumatic diseases. , 2011, Rheumatology.

[19]  J. Kingdom,et al.  Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. , 2011, Journal of the American College of Cardiology.

[20]  L. Magder,et al.  Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery , 2011, Lupus.

[21]  J. Atkinson,et al.  Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort , 2011, PLoS medicine.

[22]  J. Piette,et al.  Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. , 2011, Contraception.

[23]  L. Gai,et al.  The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. , 2011, Contraception.

[24]  F. Gadler,et al.  Development of heart block in SSA/SSB autoantibody-positive pregnancies is associated with maternal age and display a season-of-birth pattern , 2011 .

[25]  E. Chakravarty,et al.  Pregnancy outcomes after maternal exposure to rituximab. , 2011, Blood.

[26]  T. Ortel,et al.  ‘Criteria’ aPL tests: Report of a Task Force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010 , 2011, Lupus.

[27]  J. Buyon,et al.  Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies , 2011, Clinical reviews in allergy & immunology.

[28]  J. Piette,et al.  A New Presentation of Neonatal Lupus: 5 Cases of Isolated Mild Endocardial Fibroelastosis Associated with Maternal Anti-SSA/Ro and Anti-SSB/La Antibodies , 2011, The Journal of Rheumatology.

[29]  W. Branch.  Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010 , 2011, Lupus.

[30]  E. Henderson,et al.  Prescribing in pregnancy and during breast feeding: using principles in clinical practice , 2011, Postgraduate Medical Journal.

[31]  A. Tincani,et al.  Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[32]  E. Bonfá,et al.  Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs , 2010, Arthritis care & research.

[33]  L. Trupin,et al.  Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality? , 2010, Arthritis care & research.

[34]  Kent R Bailey,et al.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[35]  C. Langefeld,et al.  Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. , 2010, Arthritis and rheumatism.

[36]  A. Tincani,et al.  Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their ‘innocent’ profile? , 2010, Annals of the rheumatic diseases.

[37]  J. Buyon,et al.  Passively acquired anti-SSA/Ro antibodies are required for congenital heart block following ovodonation but maternal genes are not. , 2010, Arthritis and rheumatism.

[38]  U. Ådén,et al.  Maternal MHC Regulates Generation of Pathogenic Antibodies and Fetal MHC-Encoded Genes Determine Susceptibility in Congenital Heart Block , 2010, The Journal of Immunology.

[39]  E. Jaeggi,et al.  The Benefits of Transplacental Treatment of Isolated Congenital Complete Heart Block Associated with Maternal Anti‐Ro / SSA Antibodies: A Review , 2010, Scandinavian journal of immunology.

[40]  S. Salomonsson,et al.  Autoantibodies Associated with Congenital Heart Block , 2010, Scandinavian journal of immunology.

[41]  E. Jaeggi,et al.  Non‐Cardiac Manifestations of Neonatal Lupus Erythematosus , 2010, Scandinavian journal of immunology.

[42]  L. Hornberger,et al.  Spectrum of Cardiac Involvement in Neonatal Lupus , 2010, Scandinavian journal of immunology.

[43]  A. Tincani,et al.  Neuropsychiatric aid in children born to patients with rheumatic diseases. , 2010, Clinical and experimental rheumatology.

[44]  S. Sonesson.  Diagnosing Foetal Atrioventricular Heart Blocks , 2010, Scandinavian journal of immunology.

[45]  A. Tincani,et al.  European registry of infants born to mothers with antiphospholipid syndrome: preliminary results. , 2010, Minerva pediatrica.

[46]  Mimi Y. Kim,et al.  Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine , 2010, Annals of the rheumatic diseases.

[47]  A Tincani,et al.  Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. , 2010, Arthritis and rheumatism.

[48]  J. Rand,et al.  The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis , 2010, Lupus.

[49]  Mimi Y Kim,et al.  Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. , 2010, Arthritis and rheumatism.

[50]  Mimi Y. Kim,et al.  Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block. , 2010, Arthritis and rheumatism.

[51]  P. Izmirly,et al.  Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus , 2010, Lupus.

[52]  P. Meroni,et al.  The geoepidemiology of the antiphospholipid antibody syndrome. , 2010, Autoimmunity reviews.

[53]  J. Bellver,et al.  Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. , 2009, Fertility and sterility.

[54]  A. Algra,et al.  Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study , 2009, The Lancet Neurology.

[55]  Mimi Y. Kim,et al.  Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. , 2009, Arthritis and rheumatism.

[56]  D. Mevorach,et al.  Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block , 2009, Current opinion in rheumatology.

[57]  K. Curtis,et al.  Safety of Contraceptive Method Use Among Women With Systemic Lupus Erythematosus: A Systematic Review , 2009, Obstetrics and gynecology.

[58]  B. Källén,et al.  Early pregnancy azathioprine use and pregnancy outcomes. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[59]  Mimi Y. Kim,et al.  Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. , 2009, The American journal of cardiology.

[60]  A. Tincani,et al.  Neonatal effects of maternal antiphospholipid syndrome , 2009, Current rheumatology reports.

[61]  J. Pope,et al.  Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) is Improving: Results from a Case Control Study and Literature Review , 2008, The open rheumatology journal.

[62]  J. Buyon,et al.  Antibodies to amino acid 200–239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block , 2008, Clinical and experimental immunology.

[63]  N. Mackman,et al.  Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. , 2008, The Journal of clinical investigation.

[64]  J. Zehnder,et al.  Antithrombotic Therapy and Pregnancy: Consensus Report and Recommendations for Prevention and Treatment of Venous Thromboembolism and Adverse Pregnancy Outcomes , 2008 .

[65]  E. Myers,et al.  A national study of the complications of lupus in pregnancy. , 2008, American journal of obstetrics and gynecology.

[66]  D. Marcelli,et al.  Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[67]  A. Tincani,et al.  Challenges of lupus pregnancies. , 2008, Rheumatology.

[68]  C. Gordon,et al.  Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. , 2008, Rheumatology.

[69]  A. Brucato.  Prevention of congenital heart block in children of SSA-positive mothers. , 2008, Rheumatology.

[70]  A. Tincani,et al.  Follow-up of children exposed antenatally to immunosuppressive drugs. , 2008, Rheumatology.

[71]  X. Mariette,et al.  Rituximab (MabThera) therapy and safety management. Clinical tool guide. , 2008, Joint, bone, spine : revue du rhumatisme.

[72]  R. Straub,et al.  Oestrogens in rheumatic diseases: friend or foe? , 2008, Rheumatology.

[73]  J. Hirsh,et al.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[74]  E. Silverman,et al.  Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus , 2008, Lupus.

[75]  A. Tincani,et al.  Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. , 2008, Rheumatology.

[76]  A. Tincani,et al.  Lupus and the Antiphospholipid Syndrome in Pregnancy and Obstetrics: Clinical Characteristics, Diagnosis, Pathogenesis, and Treatment , 2008, Seminars in thrombosis and hemostasis.

[77]  Pojen P. Chen,et al.  Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic Mechanisms , 2008, Seminars in thrombosis and hemostasis.

[78]  K. Bremme,et al.  Outcome and Growth of Infants Fetally Exposed to Heart Block-Associated Maternal Anti-Ro52/SSA Autoantibodies , 2008, Pediatrics.

[79]  A. Tincani,et al.  Neuropsychological development of children born to patients with antiphospholipid syndrome. , 2008, Arthritis and rheumatism.

[80]  M. McClung,et al.  Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. , 2008, Contraception.

[81]  Mimi Y. Kim,et al.  Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study , 2008, Circulation.

[82]  G. Hughes,et al.  Heart Disease, Pregnancy and Systemic Autoimmune Diseases , 2007 .

[83]  J. Zehnder,et al.  Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. , 2007, American journal of obstetrics and gynecology.

[84]  G. Koren,et al.  Pregnancy outcome of women exposed to azathioprine during pregnancy. , 2007, Birth defects research. Part A, Clinical and molecular teratology.

[85]  A. Tincani,et al.  Immune System Development in Infants Born to Mothers with Autoimmune Disease, Exposed In Utero to Immunosuppressive Agents , 2007, American journal of perinatology.

[86]  S. Takeda,et al.  Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome , 2007, Acta obstetricia et gynecologica Scandinavica.

[87]  B. Chi,et al.  A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. , 2007, American journal of obstetrics and gynecology.

[88]  K. Cropsey,et al.  Intrauterine device use in a high-risk population: experience from an urban university clinic. , 2007, American journal of obstetrics and gynecology.

[89]  M. Motta,et al.  Therapy Insight: the use of antirheumatic drugs during nursing , 2007, Nature Clinical Practice Rheumatology.

[90]  R. Silver,et al.  Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? , 2007, Current rheumatology reports.

[91]  I. Cavazzana,et al.  Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? , 2007, Journal of autoimmunity.

[92]  A. Tincani,et al.  Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders , 2007, Lupus.

[93]  J. Shamonki,et al.  Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. , 2007, American journal of obstetrics and gynecology.

[94]  A. Tincani,et al.  Impact of in utero environment on the offspring of lupus patients , 2006, Lupus.

[95]  A. Parke.  Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases , 2006, Lupus.

[96]  A. Tincani,et al.  Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block , 2006, Lupus.

[97]  G. Mollica,et al.  Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders. , 2006, Rheumatology.

[98]  Mark A. Klebanoff,et al.  Aspirin Use and Miscarriage Risk , 2006, Epidemiology.

[99]  S. Pierangeli,et al.  A peptide that mimics the Vth region of β2glycoprotein I reverses antiphospholipid-mediated thrombosis in mice , 2006, Lupus.

[100]  C. Gordon,et al.  Anti-inflammatory and immunosuppressive drugs and reproduction , 2006, Arthritis research & therapy.

[101]  A. Tincani,et al.  Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. , 2006, American journal of perinatology.

[102]  J. Piette,et al.  The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. , 2006, Rheumatology.

[103]  A. Tincani,et al.  Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero , 2006, Annals of the rheumatic diseases.

[104]  L. Magder,et al.  Early Risk Factors for Pregnancy Loss in Lupus , 2006, Obstetrics and gynecology.

[105]  K. Kalunian,et al.  Combined oral contraceptives in women with systemic lupus erythematosus. , 2005, The New England journal of medicine.

[106]  J. Sánchez-Guerrero,et al.  A trial of contraceptive methods in women with systemic lupus erythematosus. , 2005, The New England journal of medicine.

[107]  S. Fang.  Management of preterm infants with intrauterine growth restriction. , 2005, Early human development.

[108]  L. Magder,et al.  Cyclophosphamide for lupus during pregnancy , 2005, Lupus.

[109]  D. Benhamou,et al.  Severe Pulmonary Hypertension during Pregnancy: Mode of Delivery and Anesthetic Management of 15 Consecutive Cases , 2005, Anesthesiology.

[110]  J. Craig,et al.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. , 2005, The Cochrane database of systematic reviews.

[111]  L. Magder,et al.  The impact of increased lupus activity on obstetric outcomes. , 2005, Arthritis and rheumatism.

[112]  D. Gladman,et al.  The effect of pregnancy on lupus nephritis. , 2004, Arthritis and rheumatism.

[113]  J. Rahman,et al.  Pregnancy outcome in lupus nephropathy , 2004, Archives of Gynecology and Obstetrics.

[114]  J. Salmon,et al.  Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation , 2004, Nature Medicine.

[115]  A. Tincani,et al.  Neuropsychological development of children born to patients with systemic lupus erythematosus , 2004, Lupus.

[116]  M. Østensen.  Disease specific problems related to drug therapy in pregnancy , 2004 .

[117]  P. Meroni,et al.  Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro , 2004, Annals of the rheumatic diseases.

[118]  C. Laskin,et al.  Preterm deliveries in women with systemic lupus erythematosus. , 2003, The Journal of rheumatology.

[119]  A. Tincani,et al.  Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. , 2003, Toxicology letters.

[120]  J. Piette,et al.  Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block , 2003, Annals of the rheumatic diseases.

[121]  Liyan Liu,et al.  Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study , 2003, BMJ : British Medical Journal.

[122]  R. Nass,et al.  Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. , 2003, Archives of pediatrics & adolescent medicine.

[123]  G. Koren,et al.  Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. , 2003, Birth defects research. Part B, Developmental and reproductive toxicology.

[124]  J. Piette,et al.  Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. , 2002, Seminars in arthritis and rheumatism.

[125]  S. Quaglini,et al.  Pregnancy in lupus nephritis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[126]  J. Friedman,et al.  Teratogen update: azathioprine and 6-mercaptopurine. , 2002, Teratology.

[127]  J. Buyon,et al.  Reproductive health in SLE. , 2002, Best practice & research. Clinical rheumatology.

[128]  J. Guthridge,et al.  Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss , 2002, The Journal of experimental medicine.

[129]  Y. Shoenfeld,et al.  Induction and treatment of the antiphospholipid syndrome – lessons from animal models , 2001, European journal of clinical investigation.

[130]  B. Tura,et al.  Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study , 2001, Lupus.

[131]  H. Sørensen,et al.  Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study , 2001, BMJ : British Medical Journal.

[132]  D. Branch,et al.  Management of patients with antiphospholipid antibodies undergoing in vitro fertilization. , 2000, Journal of autoimmunity.

[133]  S. Ito.  Drug therapy for breast-feeding women. , 2000, The New England journal of medicine.

[134]  J. Buyon,et al.  Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. , 2000, Arthritis and rheumatism.

[135]  K. Muir,et al.  Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. , 1999, Rheumatology.

[136]  M. Peterson,et al.  Placental pathology in systemic lupus erythematosus: a prospective study. , 1998, American journal of obstetrics and gynecology.

[137]  M. Petri,et al.  Evaluation of Preterm Delivery in a Systemic Lupus Erythematosus Pregnancy Clinic , 1995, Obstetrics and gynecology.

[138]  A. Tincani,et al.  Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. , 1994, The Journal of rheumatology.

[139]  P. Kincaid‐smith,et al.  Lupus nephritis and pregnancy. , 1992, The Quarterly journal of medicine.

[140]  J. Cameron,et al.  The Outcome of Pregnancy in Women with Lupus Nephritis , 1991, Lupus.

[141]  R. Derksen,et al.  Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[142]  N. Geschwind,et al.  Anti‐Ro Antibody in Mothers of Dyslexic Children , 1985, Developmental medicine and child neurology.

[143]  J. Steitz,et al.  The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[144]  C. W. Hart,et al.  THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE. , 1964, Archives of otolaryngology.

[145]  M. Ostensen.  Connective tissue diseases: Contraception counseling in SLE--an often forgotten duty? , 2011, Nature reviews. Rheumatology.

[146]  Chan Jun-mi,et al.  International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .

[147]  D. Chestnut.  Severe Pulmonary Hypertension During Pregnancy: Mode of Delivery and Anesthetic Management of 15 Consecutive Cases , 2006 .

[148]  J. Thurman,et al.  A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. , 2005, Molecular immunology.

[149]  J. Buyon,et al.  Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen. , 2004, Arthritis and rheumatism.

[150]  M. Ostensen.  Disease specific problems related to drug therapy in pregnancy. , 2004, Lupus.

[151]  K. Poskitt,et al.  Central Nervous System Involvement in Neonatal Lupus Erythematosus , 2003, Pediatric dermatology.

[152]  P. Fishman,et al.  Interleukin-3 and pregnancy loss in antiphospholipid syndrome. , 1998, Scandinavian journal of rheumatology. Supplement.